|
Online edition of India's National Newspaper Thursday, September 06, 2001 |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Science & Tech |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home |
|
Science & Tech
| Previous
| Next
Humans may be easier to clone than sheep
HUMANS COULD be technically easier to clone than sheep, cows,
pigs and mice because they possess a genetic benefit that
prevents foetal overgrowth, a major obstacle encountered in
cloning animals, according to new research by Duke University
Medical Centre scientists.
The genetic benefit seems subtle, say researchers, but it is so
important that it creates fundamental differences between humans
and other animals in the way they regulate foetal growth and
cancer susceptibility. The research is published in Human
Molecular Genetics. The genetic benefit they found was : humans
and primates have two activated copies of a gene - insulin-like
growth factor II receptor (IGF2R).
Offspring receive one functional copy from each parent But sheep,
pigs, mice receive only one functional copy of this gene because
of a rare phenomenon known as genomic imprinting, in which the
gene is literally stamped with markings that turn off its
function.
With the second copy of the gene permanently imprinted, such
animals are more prone to two major problems -- developing cancer
and suffering from cloning complications like overly large
offspring, immature lung development, enlarged hearts and reduced
immunity to disease, say the scientists.
"This is a concrete genetic data showing that the cloning process
could be less complicated in humans than in sheep," said Keith
Killian, a Duke University Medical Center molecular evolutionist
and first author of the study. "Only one in 300 sheep embryos
takes hold, and up to half of these embryos have large offspring
syndrome, which can kill the mother and foetus. Since humans are
not imprinted at IGF2R, then foetal overgrowth would not be
predicted to occur if humans were cloned."
The problems associated with cloning an imprinted animal occur
when scientists manipulate the fledgling embryos in the
laboratory, the Duke researchers said. While the IGF2R gene
remains intact, the "epigenetic" markings -- crucial information
layered on top of the gene sequence are inadvertently damaged and
alter the way the gene functions, said Randy Jirtle, professor of
radiation oncology at Duke. For reasons unknown, he says, the
very state of being imprinted appears to make imprinted animals
more susceptible to epigenetic damage.
However, many scientists have believed that up to 50 percent of
people are imprinted at the IGF2R gene and are more susceptible
to cancer and, potentially, cloning complications.
But scientists, found no evidence that any humans possess an
imprinted IGF2R. Also, decades of successfully manipulating human
embryos through in vitro fertilization have not resulted in large
offspring syndrome.
While it is true that the IGF2R gene is frequently mutated in
human breast, colon, head and neck, liver and lung cancers, the
researchers said that is not because humans are imprinted at
IGF2R. The gene, like any other involved in cancer, simply
becomes mutated, or defective, for a variety of reasons unrelated
to imprinting. Mutating two copies of the IGF2R gene is much more
difficult and statistically unlikely than mutating a single copy,
which is why mice and other imprinted animals are more
susceptible to cancer than are humans, said Jirtle.
Because mice and rats comprise 90 percent of the animals used in
research, scientists should take into account the rodents'
genetic susceptibility to cancer when they are applying their
study conclusions to humans, said Killian.
Clinical development of hundreds of potential disease-treating
drugs have been abandoned after rodent studies have shown them to
be potential carcinogens studies that might have had a different
outcome if rodents possessed two functional copies of IGF2R. You
could theoretically give new life to thousands of discarded
compounds by retesting them in animals that, like humans, have
both functional copies of IGF2R," said Killian.
To test for the presence of imprinting in humans and other
mammals, the Duke team used six different single nucleotide
polymorphisms, distinctive genetic markers called "SNIPs."
Scientists worldwide are now using SNIPs to map the entire human
genome because the older method, variable number tandem repeat
(VNTR), frequently produces ambiguous results. The Duke team's
results definitively showed that human IGF2R is not imprinted.
The gene is also not imprinted in primates or our closest non-
primate relatives, including tree shrews and lemurs. In fact, the
team's evolutionary research shows that all these mammals lost
imprinting of the IGF2R gene approximately 70 million years ago.
sThe modern-day absence of imprinting in all primates and their
closest relatives bolsters the team's genetic data showing that
no humans are imprinted at IGF2R, said Jirtle.
"While there are approximately 45 imprinted genes identified in
mammals, IGF2R is the only gene known to have gained imprinting
at one point and later lost it during primate evolution," said
Jirtle. In contrast, IGF2R is still imprinted in all other
placental mammals and marsupials included in their study --
including opossums, mice, rats, sheep, cows and pigs.
Send this article to Friends by E-Mail
|
|
Section : Science & Tech Previous : Insulin pill for diabetics Next : Too much soy could lead to kidney stones | |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Science & Tech |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home | |
|
Copyright © 2001 The Hindu Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu |
|